Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants

Biophysical Journal

Volumn 88, Issue 5, 2005, Pages 3133-3146

  Lee, Matthew C ^a,e   Deng, Jinxia ^b,f   Briggs, James M ^b,c   Duan, Yong ^d  

^a UNIVERSITY OF DELAWARE   (United States)

^b University of Houston   (United States)

^c University of Houston   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e United States Patent and Trademark Office   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE;

ARTICLE; CATALYSIS; CLUSTER ANALYSIS; DRUG TARGETING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN DOMAIN; THEORETICAL MODEL; VIRUS REPLICATION;

EID: 17844406393     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.104.058446     Document Type: Article

References (50)

1. Amadei, A., A. B. Linssen, and H. J. Berendsen. 1993. Essential dynamics of proteins. Proteins. 17:412-425.
2. Asante-Appiah, E., and A. M. Skalka. 1997. Molecular mechanisms in retrovirus DNA integration. Antiviral Res. 36:139-156.
3. Beese, L. S., and T. A. Steitz. 1991. Structural basis for the 3′-5′ exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism. EMBO J. 10:25-33.
4. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell. 49:347-356.
5. Bujacz, G., J. Alexandratos, Z. L. Qing, C. Clement-Mella, and A. Wlodawer. 1996. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Lett. 398:175-178.
6. Bushman, F. 1995. Targeting retroviral integration. Science. 267:1443-1444.
7. Cannon, P. M., W. Wilson, E. Byles, S. M. Kingsman, and A. J. Kingsman. 1994. Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues. J. Virol. 68:4768-4775.
8. Case, D. A., D. A. Pearlm, J. W. Caldwell, T. E. Cheatham 3rd, J. Wang, W. S. Ross, C. Simmerling, T. Darden, K. M. Merz, R. V. Stanton, and others. 2002. AMBER. Version 7. University of San Francisco, San Francisco, CA.
9. Chen, I. J., N. Neamati, and A. D. MacKerell Jr. 2002a. Structure-based inhibitor design targeting HIV-1 integrase. Curr. Drug Targets Infect. Disord. 2:217-234.
10. Chen, I. J., N. Neamati, and A. D. MacKerell Jr. 2002b. Structure-based inhibitor design targeting HIV-1 integrase. Curr. Drug Targets Infect. Disord. 2:217-234.
11. Chen, J. C., J. Krucinski, L. J. Miercke, J. S. Finer-Moore, A. H. Tang, A. D. Leavitt, and R. M. Stroud. 2000. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. USA. 97:8233-8238.
12. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald: an N-log(N) method for Ewald sums in large systems. J. Chem. Phys. 98:10089-10092.
13. Dayam, R., and N. Neamati. 2003. Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update. Curr. Pharm. Des. 9:1789-1802.
14. de Groot, B. L., D. M. van Aalten, A. Amadei, and H. J. Berendsen. 1996. The consistency of large concerted motions in proteins in molecular dynamics simulations. Biophys. J. 71:1707-1713.
15. DeLano, W. L. 2002. The PyMOL Molecular Graphics System. Version 0.95. DeLano Scientific, San Carlos, CA.
16. Drelich, M., R. Wilhelm, and J. Mous. 1992. Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology. 188:459-468.
17. Duan, Y., C. Wu, S. Chowdhury, M. C. Lee, G. Xiong, W. Zhang, R. Yang, P. Cieplak, R. Luo, T. Lee, and others. 2003. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J. Comput. Chem. 24:1999-2012.
18. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 266:1981-1986.
19. Elber, R., and M. Karplus. 1990. Enhanced sampling in molecular dynamics: use of the time-dependent Hartree approximation for a simulation of carbon monoxide diffusion through myoglobin. J. Am. Chem. Soc. 112:9161-9175.
20. Engelman, A., and R. Craigie. 1992. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66:6361-6369.
21. Engelman, A., Y. Liu, H. Chen, M. Farzan, and F. Dyda. 1997. Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase. J. Virol. 71:3507-3514.
22. Espadaler, J., N. Fernandez-Fuentes, A. Hermoso, E. Querol, F. X. Aviles, M. J. Sternberg, and B. Oliva. 2004. ArchDB: automated protein loop classification as a tool for structural genomics. Nucleic Acids Res. (database issue) 32:D185-D188.
23. Espeseth, A. S., P. Felock, A. Wolfe, M. Witmer, J. Grobler, N. Anthony, M. Egbertson, J. Y. Melamed, S. Young, T. Hamill, and others. 2000. HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase. Proc. Natl. Acad. Sci. USA. 97:11244-112449.
24. Esposito, D., and R. Craigie. 1998. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 17:5832-5843.
25. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80:379-388.
26. Gerton, J. L., S. Ohgi, M. Olsen, J. DeRisi, and P. O. Brown. 1998. Effects of mutations in residues near the active site of human immunodeficiency virus type 1 integrase on specific enzyme-substrate interactions. J. Virol. 72:5046-5055.
27. Greenwald, J., V. Le, S. L. Butler, F. D. Bushman, and S. Choe. 1999. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry. 38:8892-8898.
28. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-PDBViewer: an environment for comparative protein modeling. Electrophoresis. 18:2714-2723.
29. Johnson, M. S., M. A. McClure, D. F. Feng, J. Gray, and R. F. Doolittle. 1986. Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc. Natl. Acad. Sci. USA. 83:7648-7652.
30. Jorgensen, W. L., J. Chandrasekhar, J. Madura, and M. L. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
31. Kulkosky, J., K. S. Jones, R. A. Katz, J. P. Mack, and A. M. Skalka. 1992. Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol. Cell. Biol. 12:2331-2338.
32. Leavitt, A. D., L. Shiue, and H. E. Varmus. 1993. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J. Biol. Chem. 268:2113-2119.
33. Lins, R. D., J. M. Briggs, T. P. Straatsma, H. A. Carlson, J. Greenwald, S. Choe, and J. A. McCammon. 1999. Molecular dynamics studies on the HIV-1 integrase catalytic domain. Biophys. J. 76:2999-3011.
34. Lobel, L. I., J. E. Murphy, and S. P. Goff. 1989. The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J. Virol. 63:2629-2637.
35. Madura, J. D., J. M. Briggs, R. C. Wade, M. E. Davi, B. A. Luty, Ilin, J. Antosiewicz, M. K. Gilson, B. Bagheri, L. R. Scot, and others. 1995. Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian dynamics program. Comput. Phys. Commun. 91:57-95.
36. Oliva, B., P. A. Bates, E. Querol, F. X. Aviles, and M. J. Sternberg. 1997. An automated classification of the structure of protein loops. J. Mol. Biol. 266:814-830.
37. Oliva, B., P. A. Bates, E. Querol, F. X. Aviles, and M. J. Sternberg. 1998. Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. J. Mol. Biol. 279:1193-1210.
38. Pani, A., A. G. Loi, M. Mura, T. Marceddu, P. La Colla, and M. E. Marongiu. 2002. Targeting HIV: old and new players. Curr. Drug Targets Infect. Disord. 2:17-32.
39. Pluymers, W., E. De Clercq, and Z. Debyser. 2001. HIV-1 integration as a target for antiretroviral therapy: a review. Curr. Drug Targets Infect. Disord. 1:133-149.
40. Roitberg, A., and R. Elber. 1991. Modeling side chains in peptides and proteins: application of locally enhanced sampling and simulated annealing methods to find minimum energy conformations. J. Chem. Phys. 95:9277-9287.
41. Ryckaert, J. P., G. Ciccitti, and H. J. Berendsen. 1977. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23:327-341.
42. Sayasith, K., G. Sauve, and J. Yelle. 2000. Characterization of mutant HIV-1 integrase carrying amino acid changes in the catalytic domain. Mol. Cells. 10:525-532.
43. Sayasith, K., G. Sauve, and J. Yelle. 2001. Targeting HIV-1 integrase. Expert Opin. Ther. Targets. 5:443-464.
44. Schames, J. R., R. H. Henchman, J. S. Siegel, C. A. Sotriffer, H. Ni, and J. A. McCammon. 2004. Discovery of a novel binding trench in HIV integrase. J. Med. Chem. 47:1879-1881.
45. Tsurutani, N., M. Kubo, Y. Maeda, T. Ohashi, N. Yamamoto, M. Kannagi, and T. Masuda. 2000. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells. J. Virol. 74:4795-4806.
46. Turcotte, M., S. H. Muggleton, and M. J, Sternberg. 2001. Automated discovery of structural signatures of protein fold and function. J. Mol. Biol. 306:591-605.
47. van den Ent, F. M., A. Vos, and R. H. Plasterk. 1998. Mutational scan of the human immunodeficiency virus type 2 integrase protein. J. Virol. 72:3916-3924.
48. van Gent, D. C., A. A. Groeneger, and R. H. Plasterk. 1992. Mutational analysis of the integrase protein of human immunodeficiency virus type 2. Proc. Natl. Acad. Sci. USA. 89:9598-9602.
49. van Gent, D. C., A. A. Oude Groeneger, and R. H. Plasterk. 1993. Identification of amino acids in HIV-2 integrase involved in site-specific hydrolysis and alcoholysis of viral DNA termini. Nucleic Acids Res. 21:3373-3377.
50. Vink, C., E. Yeheskiely, G. A. van der Marel, J. H. van Boom, and R. H. Plasterk. 1991. Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein. Nucleic Acids Res. 19:6691-6698.